Duopharma Biotech Bhd (XKLS:7148) Other Net Income (Loss) : RM-0.0 Mil (TTM As of Sep. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Duopharma Biotech Bhd Other Net Income (Loss)?

Duopharma Biotech Bhd's Other Net Income (Loss) for the three months ended in Sep. 2023 was RM0.0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2023 was RM-0.0 Mil.

Duopharma Biotech Bhd's quarterly Other Net Income (Loss) increased from Mar. 2023 (RM-0.0 Mil) to Jun. 2023 (RM0.0 Mil) and increased from Jun. 2023 (RM0.0 Mil) to Sep. 2023 (RM0.0 Mil).

Duopharma Biotech Bhd Other Net Income (Loss) Historical Data

The historical data trend for Duopharma Biotech Bhd's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Duopharma Biotech Bhd Other Net Income (Loss) Chart

Duopharma Biotech Bhd Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Net Income (Loss)

Get a 7-Day Free Trial

Duopharma Biotech Bhd Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Duopharma Biotech Bhd Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-0.0 Mil.

Duopharma Biotech Bhd Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Duopharma Biotech Bhd's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Duopharma Biotech Bhd (XKLS:7148) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Duopharma Biotech Bhd (XKLS:7148) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lot 2599, Jalan Seruling 59, Kawasan 3, Taman Klang Jaya, Klang, MYS, 41200

Website

https://www.duopharmabiotech.com

Duopharma Biotech Bhd is an investment holding company engaged in manufacturing pharmaceuticals. It develops, manufactures, and markets generic and over-the-counter pharmaceutical products. The operating segment of the company is the manufacturing and distribution of pharmaceutical products. The principal activities of its subsidiary are to carry out business as a manufacturer, distributor, importer and exporter of pharmaceutical products and medicines.

Duopharma Biotech Bhd (XKLS:7148) Headlines

No Headlines